The Quidel QuickVue At-Home COVID-19 Test is authorized for prescription use and doesn’t require test samples to be sent to a lab.
Patients ages 14 and older can self-administer the test using a nose swab. The test can be used on people as young as 8 if the sample is collected by an adult, the FDA said.
The test is intended for people suspected of having COVID-19 by their healthcare provider within the first six days of their symptom onset.
Read the full news release here.
More articles on supply chain:
COVID-19 vaccine shortfall prompts UW Health to reschedule thousands of appointments
Medical devicemaker recalls patient lift after 2 deaths reported
Walgreens to sell LabCorp COVID-19 PCR test over the counter
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.